Page 15 - Génome Québec - 2016-2017 Annual Report

STATEMENT OF OPERATIONS - Year ended March 31, 2017
with 2016 comparative information

2017 2016
REVENUES

Amortization of deferred contributions related to expenses $37,694,787 $40,423,630

Amortization of deferred contributions related to 215,572 219,418
capital assets
Investment and intellectual property revenues 162,326 166,629

Revenues from technology centres 16,545,317 17,212,977
Other revenues 451,035 645,621

55 069 037 58,668,275
EXPENSES

Genomics research projects 16,913,187 21,770,354
Research projects, Québec Innovant et en Santé 13,885,311 12,501,215

Technology centres operational costs 20,461,899 21,950,950
General and administrative expenses 2,587,338 2,955,797

General and administrative expenses, Québec Innovant 128,632 131,050
et en santé

Business development and communications 147,559 300,919
Committees 13,909 60,054
Depreciatin of capital assets 215,572 219,418

Depreciation of restricted capital assets 27,930 36,560

54,381,337 59,926,317
Excess (Insufficiency) of revenues over expenses $687,700 $ (1,258,042)

ANNUAL REPORT 2016-17 15